Pelvic exenteration, the en bloc removal of the pelvic organs, is indicated for central recurrent or persistent gynecologic cancer, including cervical, endometrial, vaginal, or vulvar cancer. Even when performed in the setting of specialized centers by highly skilled surgeons, pelvic…
The standard treatment for women with early-stage cervical cancer (stages IA2–IB1) remains radical hysterectomy with pelvic lymphadenectomy. In select patients interested in future fertility, radical trachelectomy with pelvic lymphadenectomy is also considered a viable option. Data from retrospective studies have…
Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care pathway to improve functional rehabilitation after a surgical procedure, reducing the patient’s stress response in reaction to the operation and postoperative catabolism. The concept was first introduced by Kehlet, who…
Clinical case A 32-year-old G0 female presents with a newly diagnosed small cell neuroendocrine carcinoma (NEC) of the cervix. On physical exam, she is noted to have a 1.5 cm lesion on the anterior lip of the cervix with no…
Key points Ovarian cancer is the leading cause of death from gynecologic cancer, but it occurs less often than endometrial cancers. Ovarian cancers in women older than 50 years are diagnosed at a more advanced stage, leading to a worse…